• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康工作者中针对 SARS-CoV-2 核衣壳的 IgG 及亚类的血清阳性率。

Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers.

机构信息

Laboratorio de Inmunobiología y Diagnóstico Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo de los Bravo 39086, Mexico.

Unidad de Investigación en Inmunología y Proteómica, Laboratorio de Investigación en COVID-19, Hospital Infantil de México "Federico Gómez", Mexico City 06720, Mexico.

出版信息

Viruses. 2023 Apr 13;15(4):955. doi: 10.3390/v15040955.

DOI:10.3390/v15040955
PMID:37112935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10141201/
Abstract

BACKGROUND

The nucleocapsid protein of SARS-CoV-2 participates in viral replication, transcription, and assembly. Antibodies against this protein have been proposed for the epidemiological analysis of the seroprevalence of COVID-19 associated with natural infection by SARS-CoV-2. Health workers were one of the most exposed populations, and some had an asymptomatic form of the disease, so detecting IgG antibodies and subclasses against the N protein can help to reclassify their epidemiological status and obtain information about the effector mechanisms associated with viral elimination.

METHODS

In this study, we analyzed 253 serum samples collected in 2021 and derived from health workers, and evaluated the presence of total IgG and subclasses against the N protein of SARS-CoV-2 by indirect ELISA.

RESULTS

From the analyzed samples, 42.69% were positive to anti-N IgG antibodies. A correlation between COVID-19 asymptomatic infection and IgG antibodies was observed ( = 0.006). The detected subclasses were: IgG1 (82.4%), IgG2 (75.9%), IgG3 (42.6%), and IgG4 (72.6%).

CONCLUSIONS

This work provides evidence about the high seroprevalence of total IgG and subclasses of anti-N and their relations with the asymptomatic infection of SARS-CoV-2 and related symptoms.

摘要

背景

SARS-CoV-2 的核衣壳蛋白参与病毒复制、转录和组装。针对该蛋白的抗体已被提议用于对与 SARS-CoV-2 自然感染相关的 COVID-19 血清流行率进行流行病学分析。卫生工作者是暴露风险最高的人群之一,其中一些人患有无症状疾病,因此检测针对 N 蛋白的 IgG 抗体和亚类有助于重新分类他们的流行病学状况,并获得与病毒清除相关的效应机制信息。

方法

在这项研究中,我们分析了 2021 年收集的 253 份来自卫生工作者的血清样本,并通过间接 ELISA 评估了针对 SARS-CoV-2 N 蛋白的总 IgG 和亚类的存在情况。

结果

在所分析的样本中,42.69%对抗-N IgG 抗体呈阳性。观察到 COVID-19 无症状感染与 IgG 抗体之间存在相关性( = 0.006)。检测到的亚类为:IgG1(82.4%)、IgG2(75.9%)、IgG3(42.6%)和 IgG4(72.6%)。

结论

这项工作提供了关于总 IgG 和抗-N 亚类的高血清流行率及其与 SARS-CoV-2 无症状感染和相关症状之间关系的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f1/10141201/9be4dfc12141/viruses-15-00955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f1/10141201/6d4fc9c426e6/viruses-15-00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f1/10141201/9be4dfc12141/viruses-15-00955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f1/10141201/6d4fc9c426e6/viruses-15-00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f1/10141201/9be4dfc12141/viruses-15-00955-g002.jpg

相似文献

1
Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers.健康工作者中针对 SARS-CoV-2 核衣壳的 IgG 及亚类的血清阳性率。
Viruses. 2023 Apr 13;15(4):955. doi: 10.3390/v15040955.
2
Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers.检测来自哺乳期母亲的母乳和血清样本中针对 SARS-CoV-2 结构蛋白的 IgA 和 IgG 抗体。
Viruses. 2023 Apr 14;15(4):966. doi: 10.3390/v15040966.
3
Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.沙特阿拉伯一家大型 COVID-19 公立医院医护人员中 SARS-CoV-2 核衣壳抗原-IgG 的血清阳性率和持久性:一项前瞻性队列研究。
PLoS One. 2022 Aug 12;17(8):e0272818. doi: 10.1371/journal.pone.0272818. eCollection 2022.
4
Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study.墨西哥南部大学生中针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域和核衣壳的IgG抗体检测:一项横断面研究。
BMC Infect Dis. 2024 Jun 12;24(1):584. doi: 10.1186/s12879-024-09435-5.
5
Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.在一家三甲医院的医护人员和非临床工作人员中,SARS-CoV-2 核衣壳 IgG 抗体的血清流行率、相关性和动力学:一项疫苗前普查研究。
PLoS One. 2022 Oct 27;17(10):e0267619. doi: 10.1371/journal.pone.0267619. eCollection 2022.
6
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity.随着时间的推移和与疾病严重程度的关联,抗 SARS-CoV-2 IgG 亚类的变化。
Viruses. 2022 Apr 29;14(5):941. doi: 10.3390/v14050941.
7
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
8
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.在印度克什米尔第二次大流行期间,SARS-CoV-2 特异性抗刺突 IgM、IgG 和抗核衣壳 IgG 抗体的血清阳性率:一项全人群横断面调查。
Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022.
9
Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain.针对 SARS-CoV-2 抗体的 7 个多月演变:西班牙全国血清流行率 ENE-COVID 研究的经验。
J Clin Virol. 2022 Apr;149:105130. doi: 10.1016/j.jcv.2022.105130. Epub 2022 Mar 11.
10
SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France.法国西部 9 家医院在首次 COVID-19 浪潮后医护人员中 SARS-CoV-2 血清流行率和抗体持久性。
Infect Dis Now. 2022 Nov;52(8):447-452. doi: 10.1016/j.idnow.2022.09.004. Epub 2022 Sep 13.

引用本文的文献

1
Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains.36 例 COVID-19 尸检大脑中的急性中性粒细胞血管炎(白细胞碎裂性血管炎)。
Diagn Pathol. 2024 Feb 15;19(1):33. doi: 10.1186/s13000-024-01445-w.

本文引用的文献

1
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests.SARS-CoV-2 核衣壳结合抗体的交叉反应性及其对 COVID-19 血清学检测的影响。
Viruses. 2022 Sep 14;14(9):2041. doi: 10.3390/v14092041.
2
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.COVID-19 大流行期间西班牙大型医护人员队列中体液免疫反应的 17 个月动态:ProHEpiC-19 研究。
BMC Infect Dis. 2022 Sep 3;22(1):721. doi: 10.1186/s12879-022-07696-6.
3
Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019.
墨西哥儿童和青少年 2019 冠状病毒病的临床特征及基于严重急性呼吸综合征冠状病毒 2 结构蛋白的血清学研究。
PLoS One. 2022 Aug 15;17(8):e0273097. doi: 10.1371/journal.pone.0273097. eCollection 2022.
4
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
5
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia.索马里贝纳迪尔地区抗新冠病毒抗体的血清阳性率
Vaccines (Basel). 2022 Jan 30;10(2):220. doi: 10.3390/vaccines10020220.
6
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.2021 年 6 月至 7 月期间印度普通人群和医护人员中针对 SARS-CoV-2 的 IgG 抗体血清阳性率:一项基于人群的横断面研究。
PLoS Med. 2021 Dec 10;18(12):e1003877. doi: 10.1371/journal.pmed.1003877. eCollection 2021 Dec.
7
Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.严重和中度 COVID-19 患者的抗体和细胞因子谱存在差异。
Front Immunol. 2021 Aug 19;12:723585. doi: 10.3389/fimmu.2021.723585. eCollection 2021.
8
Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19.抗 SARS-CoV-2 IgG 水平与 COVID-19 疾病严重程度的关系。
J Med Virol. 2022 Jan;94(1):380-383. doi: 10.1002/jmv.27274. Epub 2021 Aug 21.
9
Overview of SARS-CoV-2 genome-encoded proteins.SARS-CoV-2 基因组编码蛋白概述。
Sci China Life Sci. 2022 Feb;65(2):280-294. doi: 10.1007/s11427-021-1964-4. Epub 2021 Aug 10.
10
Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.在芝加哥的医护人员中进行的一项队列研究:长达 6 个月的随访中血清学状态和 SARS-CoV-2 感染情况。
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1207-1215. doi: 10.1017/ice.2021.367. Epub 2021 Aug 9.